|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Amyloid Beta (1-42) ELISA Assay | Amyloid Beta (N3pE-40) ELISA Assay | Anti-Ustekinumab (Stelara®) ELISA | Coxiella burnetii (Q-Fever) Phase 1 IgG ELISA Assay | GPIHBP1 Autoantibody ELISA |
| Citations | | | | | |
| Catalog Number | 27711 | 27418 | TM09036 | IB79833 | 27267 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Human Aß (N3pE-40) in brain tissue extract. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the determination of IgG class antibodies against Coxiella burnetii phase 1 in the early stages of infection in human serum. For research use only, not for use in diagnostic procedures. | Indirect ELISA for the determination of human GPIHBP1 Autoantibody in serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | Anti-Cetuximab (Erbitux®) | sAPP Total | Coxiella burnetii (Q-Fever) Phase 1 IgG | Progesterone |
| Sample Type | Serum and plasma. | Serum and plasma. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 12.5 to 800 pg/mL | 3.13 to 200 pg/mL | Anti-Ustekinumab (Stelara®) | Inquire | 0 / 0.008 - 0.50 U/mL |
| Sensitivity | 1 ng/mL | 1.5 ng/mL | 0.06 ng/mL | 88% | 0.05 ng/mL |
| Assay Time | Overnight + 1 hr 30 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hour, 30 min. total incubation time. | 1 hr 45 mins (incubation) | 2 hour total incubation time. |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |